Platinum and Taxane Chemo in Met Castration Resistant Prostate Cancer Patients With Alterations in DNA Damage Response Genes

NCT06439225 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

236

Enrollment

NETWORK

Sponsor class

Conditions

Metastatic Castration-resistant Prostate Cancer
Metastatic Prostate Cancer

Interventions

DRUG: Docetaxel
DRUG: Carboplatin

Sponsor

Canadian Cancer Trials Group

Collaborators

[object Object]